Brief: Biotec Pharmacon Q2 Gross Profit Improved 42% To NOK 11.6 Mln

Arcticzymes Technologies ASA

15/08/2019 06:19

Aug 15 (Reuters) - Biotec Pharmacon ASA  BIOTEC.OL :
    * Q2 SALES NOK 16.9 MILLION VERSUS NOK 10.9 MILLION YEAR AGO
    * Q2 GROSS PROFIT FOR GROUP IMPROVED 42% TO NOK 11.6 MILLION
(Q2
2018: NOK 8.2 MILLION) DUE TO IMPROVEMENTS IN MOST AREAS.
    * PERFORMANCE IN Q2 CONTINUED POSITIVE DEVELOPMENT FROM Q1

Source text for Eikon:  ID:nObicvVF6a 
Further company coverage:  BIOTEC.OL 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))